Patents by Inventor Bonita S. Dunbar

Bonita S. Dunbar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic epitopes of the human zona pellucida protein (ZP1)
    Patent number: 6455041
    Abstract: Immunogenic epitopes of human zona pellucida protein useful in inducing antibodies to zona pellucida protein.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: September 24, 2002
    Inventor: Bonita S. Dunbar
  • Monoclonal antibody for diagnostic and therapeutic use in ovarian cancer
    Patent number: 6048528
    Abstract: A method for the diagnosis and treatment of ovarian cancer. Tissue and body fluid samples are assayed for an antigen which specifically binds an anti-OSE antigen to diagnose ovarian cancer. Therapeutic agents coupled to anti-OSE antibodies, such as PS1 are specifically directed to ovarian cancer tissues.
    Type: Grant
    Filed: November 24, 1997
    Date of Patent: April 11, 2000
    Assignee: Baylor College of Medicine
    Inventor: Bonita S. Dunbar
  • Monoclonal antibody for diagnostic use in ovarian cancer
    Patent number: 5484704
    Abstract: A method for the diagnosis and treatment of ovarian cancer. Tissue and body fluid samples are assayed for an antigen which specifically binds an anti-OSE antibody to diagnose ovarian cancer.
    Type: Grant
    Filed: October 19, 1994
    Date of Patent: January 16, 1996
    Assignee: Baylor College of Medicine
    Inventor: Bonita S. Dunbar
  • Recombinantly expressed rabbit zona pellucida polypeptides
    Patent number: 4996297
    Abstract: The invention relates to antigenic preparations useful for inducing the production of antibodies in an individual which will bind to epitopes on zona pellucida. Also disclosed are immunogenic compositions and methods for immunizing an individual to enable the production of antibodies to zona pellucida antigens. Also disclosed are the use of these recombinant molecules and monoclonal antibodies thereto for immunocontraception or sterilization.
    Type: Grant
    Filed: October 7, 1987
    Date of Patent: February 26, 1991
    Assignee: Zonagen, Inc.
    Inventor: Bonita S. Dunbar